E Fund Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.9K Buy
+10,710
New +$111K ﹤0.01% 475
2025
Q2
Sell
-10,383
Closed -$50.5K 410
2025
Q1
$50.5K Buy
10,383
+145
+1% +$1.2K ﹤0.01% 392
2024
Q4
$97.9K Buy
+10,238
New +$93.9K ﹤0.01% 379
2023
Q3
Sell
-31,274
Closed -$230K 300
2023
Q2
$230K Buy
31,274
+9,528
+44% +$88.4K 0.02% 260
2023
Q1
$225K Sell
21,746
-20
-0.1% -$242 0.02% 277
2022
Q4
$257K Buy
21,766
+5,618
+35% +$86.9K 0.02% 254
2022
Q3
$339K Buy
16,148
+1,508
+10% +$42K 0.03% 216
2022
Q2
$454K Buy
14,640
+7,286
+99% +$249K 0.04% 160
2022
Q1
$302K Buy
+7,354
New +$324K 0.01% 192

Other funds holding EBS